HIV-1 Is Associated with Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women

Journal of Infectious Diseases

Volumn 212, Issue 3, 2015, Pages 453-462

  Dangor, Ziyaad ^a,b,c   Kwatra, Gaurav ^a,b   Izu, Alane ^a,b   Adrian, Peter ^a,b   Van Niekerk, Nadia ^a,b   Cutland, Clare L ^a,b   Adam, Yasmin ^d   Velaphi, Sithembiso ^c   Lala, Sanjay G ^c   Madhi, Shabir A ^a,b,e  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b Department of Science and Technology   (United States)

^c Faculty of Health Sciences   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e National Institute for Communicable Diseases A Division of National Health Laboratory Service Centre for Vaccines and Immunology   (United Kingdom)

Author keywords

antibody; Group B Streptococcus; HIV; immunity; Streptococcus agalactiae; transplacental transfer

Indexed keywords

FIBRINOGEN; FIBRINOGEN BINDING PROTEIN A; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BACTERIUM PILUS; CAPSULAR ANTIBODY CONCENTRATION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CORD MATERNAL RATIO; DISEASE PREDISPOSITION; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SEROTYPE; VIRUS LOAD; ADOLESCENT; BACTERIAL CAPSULE; BLOOD; CROSS-SECTIONAL STUDY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; STREPTOCOCCUS AGALACTIAE; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

EID: 84939543279     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv064     Document Type: Article

References (44)

1. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive earlyonset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011; 30:937-41.
2. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011; 364:2016-25.
3. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012; 379:547-56.
4. Dagnew AF, Cunnington MC, Dube Q, et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis 2012; 55:91-102.
5. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005; 352:39-47.
6. Gray KJ, Bennett SL, French N, Phiri AJ, Graham SM. Invasive group B streptococcal infection in infants,Malawi. Emerg Infect Dis 2007; 13:223-9.
7. Cutland CL, Madhi SA, Zell ER, et al. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: A randomised, controlled trial. Lancet 2009; 374:1909-16.
8. Dangor Z, Kwatra G, Izu A, Lala SG, Madhi SA. Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants. Expert Rev Vaccines 2015; 14:135-49.
9. Lindahl G, Stalhammar-Carlemalm M, Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 2005; 18:102-27.
10. Margarit I, Rinaudo CD, Galeotti CL, et al. Preventing bacterial infections with pilus-based vaccines: The group B streptococcus paradigm. J Infect Dis 2009; 199:108-15.
11. Meinke AL, Senn BM, Visram Z, et al. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens. Vaccine 2010; 28:6997-7008.
12. El Beitune P, Duarte G, Maffei CM, Quintana SM, De Sa Rosa ESAC, Nogueira AA. Group B Streptococcus carriers among HIV-1 infected pregnant women: prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol 2006; 128:54-8.
13. Mavenyengwa RT, Moyo SR, Nordbo SA. Streptococcus agalactiae colonization and correlation with HIV-1 and HBV seroprevalence in pregnant women fromZimbabwe. Eur J Obstet Gynecol Reprod Biol 2010; 150:34-8.
14. Shah M, Aziz N, Leva N, Cohan D. Group B Streptococcus colonization by HIV status in pregnant women: prevalence and risk factors. J Womens Health 2011; 20:1737-41.
15. Gray KJ, Kafulafula G, Matemba M, Kamdolozi M, Membe G, French N. Group B Streptococcus and HIV infection in pregnant women, Malawi, 2008-2010. Emerg Infect Dis 2011; 17:1932-5.
16. Cutland CL, Schrag SJ, Zell ER, et al. Maternal HIV infection and vertical transmission of pathogenic bacteria. Pediatrics 2012; 6:6.
17. Epalza C, Goetghebuer T, Hainaut M, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010; 126:23.
18. Cutland CL, Schrag SJ, Thigpen MC, et al. Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008. Emerg Infect Dis 2015; doi:10.3201/eid2104.141562.
19. Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: A growing population with a vulnerable immune system? Clin Exp Immunol 2014; 176:11-22.
20. District Research Committee. Birth statistics. Johannesburg: Johannesburg Health District. Gauteng Department of Health, 2014.
21. National Department of Health. Clinical Guidelines: PMTCT (Prevention of Mother-to-Child Transmission). Pretoria: National Department of Health, South Africa, 2010.
22. National Department of Health. The South African Antiretroviral Treatment Guidelines, PMTCT Guidelines: Revised March 2013. South Africa: Department of Health, 2013:8.
23. Boyer KM, Papierniak CK, Gadzala CA, Parvin JD, Gotoff SP. Transplacental passage of IgG antibody to group B streptococcus serotype Ia. J Pediatr 1984; 104:618-20.
24. Lagergard T, Thiringer K, Wassen L, Schneerson R, Trollfors B. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk. Eur J Pediatr 1992; 151:98-102.
25. Schlottmann SA, Jain N, Chirmule N, Esser MT. A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheres. J Immunol Methods 2006; 309:75-85.
26. Ditse Z, Adrian PV, Kuwanda L, Madhi SA. Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children. Vaccine 2013; 31:4421-7.
27. Kwatra G, Adrian PV, Shiri T, Buchmann EJ, Cutland CL, Madhi SA. Serotype-specific acquisition and loss of group B streptococcus rectovaginal colonization in late pregnancy. PLOS One 2014; 9:e98778.
28. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011; 305: 576-84.
29. Gupta A, Mathad JS, Yang WT, et al. Maternal pneumococcal capsular IgG antibodies and transplacental transfer are low in South Asian HIVinfected mother-infant pairs. Vaccine 2014; 32:1466-72.
30. Kruczek A, Cutland CL, Madhi SA. Effect of maternal HIV infection on measles susceptibility during early infancy: implications for optimizing protection of the infant. HIV Ther 2010; 4:1-12.
31. Davies HD, Adair C, McGeer A, et al. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis 2001; 184:285-91.
32. Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Schrag SJ, Madhi SA. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLOS One 2011; 6:e17861.
33. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012; 2012:985646.
34. de Moraes-Pinto MI, Almeida AC, Kenj G, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 1996; 173:1077-84.
35. Scott S, Cumberland P, Shulman CE, et al. Neonatal measles immunity in rural Kenya: The influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis 2005; 191:1854-60.
36. Cumberland P, Shulman CE, Maple PA, et al. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis 2007; 196:550-7.
37. Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014; 371:918-31.
38. Leach JL, Sedmak DD, Osborne JM, Rahill B, Lairmore MD, Anderson CL. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol 1996; 157:3317-22.
39. de Moraes-Pinto MI, Farhat CK, Fraser WD, Hart CA, Johnson PM. Human serum beta2-microglobulin levels: correlation with total serum IgG and placental IgG transfer in HIV-infected and non-HIV infected individuals. J Reprod Immunol 1999; 42:167-74.
40. Taron-Brocard C, Le Chenadec J, Faye A, et al. Increased risk of serious bacterial infections due to maternal immunosuppression in HIVexposed uninfected infants in a European country. Clin Infect Dis 2014; 59:1332-45.
41. Farquhar C, Nduati R, Haigwood N, et al. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody. J Acquir Immune Defic Syndr 2005; 40: 494-7.
42. Brigtsen AK, Kasper DL, Baker CJ, Jennings HJ, Guttormsen HK. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines. J Infect Dis 2002; 185: 1277-84.
43. Shen X, Lagergard T, Yang Y, Lindblad M, Fredriksson M, Holmgren J. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharidecholera toxin B subunit conjugate vaccine. Infect Immun 2000; 68: 5749-55.
44. Heyderman R, French N, Madhi S, et al. Safety and Immunogenicity of Investigational Group B Streptococcus Trivalent Polysaccharide-Conjugate Vaccine in HIV-infected and Uninfected Pregnant African Women and Newborns. [Abstract 158]. In: European Society for Paediatric Infectious Diseases. Dublin, Ireland, 2014.